Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

pulveris, -

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

pulveris, -

Latvija - latviešu - Zāļu valsts aģentūra

b.braun melsungen ag, germany - propofols - emulsija injekcijām/infūzijām - 10 mg/ml

Latvija - latviešu - Zāļu valsts aģentūra

b.braun melsungen ag, germany - isoleucinum, leucinum, lysinum, methioninum, phenylalaninum, threoninum, tryptophanum, valinum, argininum, histidinum, alaninum, skābes asparticum, skābes glutamicum, glycinum, prolinum, serinum, natrii hydroxidum, natrii chloridum, natrii acetas trihydricus, kalii acetas, magnija acetas tetrahydricus, kalcija chloridum dihydricum, glikozes monohydricum, natrii dihydrogenophosphas dihydricus, zinci acetas dihydricus, triglycerida saturata mediju, soiae naftas raffinatum, omega-3 acidorum triglycerida - emulsija infūzijām

Latvija - latviešu - Zāļu valsts aģentūra

b.braun melsungen ag, germany - isoleucinum, leucinum, lysinum, methioninum, phenylalaninum, threoninum, tryptophanum, valinum, argininum, histidinum, alaninum, acidum asparticum, acidum glutamicum, glycinum, prolinum, serinum, natrii hydroxidum, natrii chloridum, natrii acetas trihydricus, kalii acetas, magnesii acetas tetrahydricus, calcii chloridum dihydricum, glucosum monohydricum, natrii dihydrogenophosphas dihydricus, zinci acetas dihydricus, triglycerida saturata media, soiae oleum, omega-3 acidorum triglycerida - emulsija infūzijām

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cūkas - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

b.braun medical sia - šķidrums

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

b.braun medical sia - šķidrums

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

b.braun medical sia - šķidrums

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

b.braun medical sia - šķidrums